Ketamine based drug should be available for treatment resistant depression, says FDA panel

被引：0
|
作者：
Silberner, Joanne
机构：
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2019年 / 364卷
关键词：
D O I：
10.1136/bmj.l858
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：1
相关论文
共 50 条
  • [21] EU drug approval should include price evaluation, says expert panel
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2019, 367 : l6591
  • [22] KETAMINE FOR TREATMENT-RESISTANT DEPRESSION: A NEW ADVOCATE
    Perez-Esparza, Rodrigo
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2018, 70 (02): : 65 - 67
  • [23] Following Ketamine Infusion in Individuals With Treatment Resistant Depression
    Deckersbach, Thilo
    Testo, Abigail
    Ionescu, Dawn
    Felicione, Julia
    Akeju-Johnson, Oluwaseun
    Cheung, Joey
    Kubicki, Marek
    Cusin, Christina
    Dougherty, Darin
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S308 - S309
  • [24] Maintenance Ketamine Therapy for Treatment-Resistant Depression
    Archer, Shaina
    Chrenek, Carson
    Swainson, Jennifer
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (04) : 380 - 384
  • [25] The role of intranasal ketamine in treatment-resistant depression
    Costa, M.
    Fraga, M.
    Moutinho, A.
    Cintra, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S492 - S492
  • [26] INTRAVENOUS KETAMINE FOR TREATMENT-RESISTANT DEPRESSION IN ADOLESCENTS?
    Cullen, Kathryn R.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S284 - S284
  • [27] SUICIDALITY IN TREATMENT RESISTANT DEPRESSION: PERSPECTIVE FOR KETAMINE USE
    Jakuszkowiak-Wojten, Katarzyna
    Galuszko-Wegielnik, Maria
    Wilkowska, Alina
    Slupski, Jakub
    Wlodarczyk, Adam
    Gorska, Natalia
    Szarmach, Joanna
    Szalach, Lukasz P.
    Wiglusz, Mariusz S.
    Krysta, Krzysztof
    Cubala, Wieslaw Jerzy
    PSYCHIATRIA DANUBINA, 2019, 31 : S258 - S260
  • [28] Magnesium in Ketamine Administration in Treatment-Resistant Depression
    Gorska, Natalia
    Cubala, Wieslaw Jerzy
    Slupski, Jakub
    Wiglusz, Mariusz Stanislaw
    Galuszko-Wegielnik, Maria
    Kawka, Mateusz
    Grzegorzewska, Agata
    PHARMACEUTICALS, 2021, 14 (05)
  • [29] A systematic review of ketamine for treatment-resistant depression
    Patel, Reshmee
    Loh, Feng-Hua
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 132 - 132
  • [30] The use of subcutaneous ketamine for treatment-resistant depression
    Vargas Alves Nunes, A.
    Carrara, E.
    Odebrecht Vargas Nunes, S.
    Fernandes Jorge, I.
    Alves, E.
    Haddad, M.
    EUROPEAN PSYCHIATRY, 2019, 56 : S95 - S95
12345